2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
47
Lung Neoplasms
29
Neoplasms
27
Colorectal Neoplasms
21
Prostatic Neoplasms
16
Hematologic Neoplasms
10
Uterine Cervical Neoplasms
9
Fatigue
9
Anxiety Disorders
8
Neoplasm Metastasis
7
Lymphoma
7
Hematopoietic and Lymphatic System Neoplasm
7
Papillomavirus Infections
6
Melanoma
6
Ovarian Neoplasms
5
Multiple Myeloma
5
Head and Neck Neoplasms
5
Gastrointestinal Neoplasms
5
Depression
5
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Skin Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Obesity
4
Motor Activity
4
Hematopoietic and Lymphoid System Neoplasm
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Interventions
Paclitaxel
2
Carboplatin
2
selinexor
1
pazopanib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Pregnancy Tests
1
Naproxen
1
Human Papillomavirus DNA Tests
1
GX-188 vaccine
1
Filgrastim
1
Educational Status
1
Drug Therapy
1
Colposcopy
1
Biopsy
1
Anesthesia, General
1
Acetic Acid
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Diseases
×
Educational Status
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts